Cargando…
Clinical decisions surrounding genomic and proteomic testing among United States veterans treated for lung cancer within the Veterans Health Administration
BACKGROUND: Current clinical guidelines recommend epidermal growth factor receptor (EGFR) mutational testing in patients with metastatic non-small cell lung cancer (NSCLC) to predict the benefit of the tyrosine kinase inhibitor erlotinib as first-line treatment. Proteomic (VeriStrat) testing is reco...
Autores principales: | Efimova, Olga, Berse, Brygida, Denhalter, Daniel W., DuVall, Scott L., Filipski, Kelly K., Icardi, Michael, Kelley, Michael J., Lynch, Julie A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450357/ https://www.ncbi.nlm.nih.gov/pubmed/28558785 http://dx.doi.org/10.1186/s12911-017-0475-8 |
Ejemplares similares
-
Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy Users
por: Chanfreau-Coffinier, Catherine, et al.
Publicado: (2019) -
Identification of methicillin-resistant Staphylococcus aureus within the Nation’s Veterans Affairs Medical Centers using natural language processing
por: Jones, Makoto, et al.
Publicado: (2012) -
Phenome-wide association of 1809 phenotypes and COVID-19 disease progression in the Veterans Health Administration Million Veteran Program
por: Song, Rebecca J., et al.
Publicado: (2021) -
Transgender Veterans and the Veterans Health Administration: Exploring the Experiences of Transgender Veterans in the Veterans Affairs Healthcare System
por: Rosentel, Kris, et al.
Publicado: (2016) -
Suicide risk following a new cancer diagnosis among Veterans in Veterans Health Administration care
por: Dent, Kallisse R., et al.
Publicado: (2022)